Berkshire Hathaway Inc. vs Pfizer Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Berkshire Hathaway Inc. (BRK-B) carries a "Neutral" signal with +0.7% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Financials and Healthcare sectors.
| Metric | Berkshire Hathaway Inc. (BRK-B) | Pfizer Inc. (PFE) |
|---|---|---|
| Operator Signal | Neutral | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $93.7B | $14.5B |
| Revenue Growth | 0.7%* | -18.4% |
| Latest EPS | N/A | $0.47 |
| EPS Growth | N/A | -39.7% |
| Sector | Financials | Healthcare |
| Quarters Tracked | 8 | 8 |
Berkshire Hathaway Inc. (BRK-B) carries a "Neutral" signal with +0.7% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Financials and Healthcare sectors.